Valacyclovir Alternatives Compared
| Valacyclovir | Kesimpta (ofatumumab) | Copaxone (glatiramer) |
|
|---|
| Valacyclovir | Kesimpta (ofatumumab) | Copaxone (glatiramer) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Valacyclovir is used to treat cold sores, genital herpes, herpes zoster, and chickenpox. It is an antiviral prodrug that is rapidly converted into acyclovir in the body. Valacyclovir should be... View more |
Prescription only
Prescribed for Multiple Sclerosis. Kesimpta may also be used for purposes not listed in this medication guide. |
Prescription only
Copaxone is a combination of four amino acids that may be given to treat relapsing forms of multiple sclerosis in adults. It has been shown to significantly reduce the number of relapses but may be... View more |
Related suggestions |
|||||||||||||||
| More about Valacyclovir | More about Kesimpta (ofatumumab) | More about Copaxone (glatiramer) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Valacyclovir has an average rating of 8.3 out of 10 from a total of 495 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 12% reported a negative effect. |
Kesimpta has an average rating of 7.0 out of 10 from a total of 81 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 17% reported a negative effect. |
Copaxone has an average rating of 7.5 out of 10 from a total of 134 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Valacyclovir side effects |
View all Kesimpta side effects |
View all Copaxone side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Valacyclovir prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Copaxone prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Valtrex | Other ofatumumab brands include: Arzerra | Other glatiramer brands include: Glatopa | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
3.1 hours |
1476 hours |
1 hour |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 92 drugs are known to interact with Valacyclovir:
|
A total of 182 drugs are known to interact with Kesimpta:
|
A total of 1 drugs are known to interact with Copaxone:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
June 23, 1995 |
N/A |
December 20, 1996 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.